EUROBIO-SCIENTIFIC (ALERS.PA) Stock Overview
EPA:ALERS - FR0013240934 - Common Stock
ALERS.PA Key Statistics, Chart & Performance
The current stock price of ALERS.PA is 25.25 EUR. In the past month the price increased by 0.6%. In the past year, price increased by 1.81%.
ALERS.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 20.11 | 322.93B | ||
| 1ABBV.MI | ABBVIE INC | 19.56 | 314.07B | ||
| AMG.DE | AMGEN INC | 12.96 | 130.58B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 14.78 | 122.10B | ||
| GIS.DE | GILEAD SCIENCES INC | 14.63 | 120.51B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 23.46 | 87.47B | ||
| ARGX.BR | ARGENX SE | 85.21 | 38.64B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.03B | ||
| IDP.DE | BIOGEN INC | 8.63 | 17.39B | ||
| 0QF.DE | MODERNA INC | N/A | 7.97B | ||
| 1MRNA.MI | MODERNA INC | N/A | 7.96B | ||
| 1EXAS.MI | EXACT SCIENCES CORP | N/A | 7.29B |
Related stock screener links
About ALERS.PA
Company Profile
Eurobio-Scientific SA provides in vitro diagnostics solutions. The company is headquartered in Les Ulis, Ile-De-France and currently employs 326 full-time employees. The company went IPO on 2005-11-18. The company is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The firm owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. The company consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. The company has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. The company operates through Genbio and Eurobio Capforce Plus.
Company Info
EUROBIO-SCIENTIFIC
ZA de Courtaboeuf 7 Avenue de Scandinavie, Les Ulis Cedex
Les Ulis ILE-DE-FRANCE FR
Employees: 329
Phone: 331169796480
EUROBIO-SCIENTIFIC / ALERS.PA FAQ
What is the stock price of EUROBIO-SCIENTIFIC today?
The current stock price of ALERS.PA is 25.25 EUR. The price decreased by -0.2% in the last trading session.
What is the ticker symbol for EUROBIO-SCIENTIFIC stock?
The exchange symbol of EUROBIO-SCIENTIFIC is ALERS and it is listed on the Euronext Paris - Matif exchange.
On which exchange is ALERS.PA stock listed?
ALERS.PA stock is listed on the Euronext Paris - Matif exchange.
What is the price forecast or stock price prediction for EUROBIO-SCIENTIFIC stock?
9 analysts have analysed ALERS.PA and the average price target is 30.6 EUR. This implies a price increase of 21.19% is expected in the next year compared to the current price of 25.25. Check the EUROBIO-SCIENTIFIC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is EUROBIO-SCIENTIFIC worth?
EUROBIO-SCIENTIFIC (ALERS.PA) has a market capitalization of 258.81M EUR. This makes ALERS.PA a Micro Cap stock.
How many employees does EUROBIO-SCIENTIFIC have?
EUROBIO-SCIENTIFIC (ALERS.PA) currently has 329 employees.
What are the support and resistance levels for EUROBIO-SCIENTIFIC (ALERS.PA) stock?
EUROBIO-SCIENTIFIC (ALERS.PA) has a support level at 25 and a resistance level at 25.28. Check the full technical report for a detailed analysis of ALERS.PA support and resistance levels.
Is EUROBIO-SCIENTIFIC (ALERS.PA) expected to grow?
The Revenue of EUROBIO-SCIENTIFIC (ALERS.PA) is expected to grow by 9.49% in the next year. Check the estimates tab for more information on the ALERS.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy EUROBIO-SCIENTIFIC (ALERS.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALERS.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALERS.PA, evaluating the profitability, health, valuation and growth aspects
- EUROBIO-SCIENTIFIC (ALERS.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- EUROBIO-SCIENTIFIC (ALERS.PA) Sales and EPS estimates to see what analysts future expectations are.
- EUROBIO-SCIENTIFIC (ALERS.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- EUROBIO-SCIENTIFIC (ALERS.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- EUROBIO-SCIENTIFIC (ALERS.PA) Stock Chart to make your own analysis
- EUROBIO-SCIENTIFIC (ALERS.PA) Latest news and press-releases to stay up to date.
Does EUROBIO-SCIENTIFIC (ALERS.PA) stock pay dividends?
ALERS.PA does not pay a dividend.
When does EUROBIO-SCIENTIFIC (ALERS.PA) report earnings?
EUROBIO-SCIENTIFIC (ALERS.PA) will report earnings on 2025-10-21.
What is the Price/Earnings (PE) ratio of EUROBIO-SCIENTIFIC (ALERS.PA)?
The PE ratio for EUROBIO-SCIENTIFIC (ALERS.PA) is 63.13. This is based on the reported non-GAAP earnings per share of 0.4 and the current share price of 25.25 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ALERS.PA.
ALERS.PA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALERS.PA. When comparing the yearly performance of all stocks, ALERS.PA is a bad performer in the overall market: 64.87% of all stocks are doing better.
ALERS.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to ALERS.PA. ALERS.PA has an excellent financial health rating, but there are some minor concerns on its profitability.
ALERS.PA Financial Highlights
Over the last trailing twelve months ALERS.PA reported a non-GAAP Earnings per Share(EPS) of 0.4. The EPS decreased by -7.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.59% | ||
| ROA | 1.55% | ||
| ROE | 2.24% | ||
| Debt/Equity | 0.17 |
ALERS.PA Forecast & Estimates
9 analysts have analysed ALERS.PA and the average price target is 30.6 EUR. This implies a price increase of 21.19% is expected in the next year compared to the current price of 25.25.
For the next year, analysts expect an EPS growth of 31.82% and a revenue growth 9.49% for ALERS.PA